Article: "Pipeline Insight: Neuropathic Pain - Pipeline Drugs Fail to Nail Neuropathic Pain" by Datamonitor July 2005.

M2 PRESSWIRE-16 August 2005-MarketResearch.com: "Pipeline Insight: Neuropathic Pain - Pipeline Drugs Fail to Nail Neuropathic Pain" by Datamonitor July 2005(C)1994-2005 M2 COMMUNICATIONS LTD

RDATE:15082005

The neuropathic pain market has traditionally been a poorly defined area, with widely varying drug classes prescribed. With many drugs now in clinical trials for key neuropathic pain sub-types, pharma companies with powerful marketing arms are expected to bring attention to this potentially lucrative market and its considerable unmet needs.

Scope

~ Overview of patient potential, segmentation by indication and unmet needs in ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!